Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mudanjiang Lingtai Pharmaceuticals is a Chinese pharmaceutical company based in Mudanjiang, Heilongjiang Province, specializing in the research, development, and manufacturing of Traditional Chinese Medicine (TCM) and chemical drugs. As a key subsidiary of China Meheco Group Co., Ltd., the company is particularly recognized for its expertise in hepatology, with its flagship product Bao Gan Ning serving as a leading treatment for liver protection and hepatitis. Its diverse product portfolio also encompasses therapeutic areas such as cardiovascular health, respiratory infections, and digestive disorders. The company operates modern, GMP-certified manufacturing facilities for various dosage forms, including capsules, tablets, and granules. Mudanjiang Lingtai leverages the extensive distribution network and resources of its parent company to maintain a significant presence in the Chinese domestic market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mudanjiang Lingtai Pharmaceuticals.